Fractyl Health, Inc. GUTS
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.19% | -23.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.28% | -10.58% | |||
| Operating Income | 8.28% | 10.58% | |||
| Income Before Tax | -377.04% | 121.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -377.04% | 121.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -377.04% | 121.08% | |||
| EBIT | 8.28% | 10.58% | |||
| EBITDA | 8.38% | 10.72% | |||
| EPS Basic | -376.79% | 118.69% | |||
| Normalized Basic EPS | -345.54% | 120.35% | |||
| EPS Diluted | -376.79% | 118.69% | |||
| Normalized Diluted EPS | -345.54% | 120.35% | |||
| Average Basic Shares Outstanding | 0.10% | 12.77% | |||
| Average Diluted Shares Outstanding | 0.10% | 12.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||